Caisse des dépôts et consignations (CDC) has declared to the AMF that on November 23, through the intermediary of Bpifrance Participations and Bpifrance Investissement, it fell below the thresholds of 5% of the capital and voting rights in GenSight Biologics.

Following this crossing, which resulted from a capital increase by the company, the public financial institution stated that it indirectly held 2,399,681 GenSight shares, representing 3.67% of the capital and voting rights of this biopharmaceutical company.

Copyright (c) 2023 CercleFinance.com. All rights reserved.